2015 World STI & HIV Congress and Australasian HIV&AIDS Conference
 
9 January 2015



Abstract Submission Opening Soon!
World STI & HIV Congress
13-16 September 2015
Brisbane, Australia


The call for abstracts will open on 2 February 2015. Start writing your abstract now - to review the guidelines - PLEASE CLICK HERE.  Step-by-step instructions including an abstract template are outlined on the website www.worldsti2015.com

The World STI & HIV Congress conveners are the International Society for STD Research (ISSTDR) and International Union against STI (IUSTI). The Congress incorporates the Australasian Sexual Health Conference. The Australasian Sexual Health Association (ASHA) hosts this annual educational conference for the benefit of fellows, trainees, general practitioners and anyone involved in sexual health medicine. The congress will be held back-to-back with the Australasian Society for HIV Medicine (ASHM) Conference, 16-19 September 2015. The conference program on 16 September specifically highlights overlaps between STI and HIV science.

The Congress theme, "Up and Coming" signifies our commitment to the promotion of emerging and outstanding international researchers across a range of scientific disciplines. It will highlight global research with a special focus on the Asia Pacific region and research into the sexual health of vulnerable populations; including Indigenous people, ethnic minorities, and sexual/gender minorities.

Plenary speaker highlights!

Professor Myron (Mike) Cohen


Professor Cohen is the architect and principal investigator of the multinational HPTN 052 trial which demonstrated that antiretroviral treatment prevents the sexual transmission of HIV-1. This work was recognized by Science Magazine as the “Breakthrough of the Year” in 2011. He is the J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology and Epidemiology at the University of North Carolina at Chapel Hill. He also serves as chief of the Division of Infectious Diseases, Director of the Institute for Global Health & Infectious Diseases, and Associate Vice Chancellor for Global Health.


Professor Helen Rees OBE


Professor Rees is one of South Africa’s most well-known women scientists. Her research interests include HIV/AIDS prevention, STIs, microbicides, HIV and HPV vaccines, and broader issues relating to women’s health. Professor Rees serves as a technical expert to the Global Alliance on Vaccines and Immunization, the HIV Vaccine Advisory Committee and the HPV Vaccine expert committee of the World Health Organization, the Population Council and the US National Institutes of Health. In 2004 she became the first woman to be awarded the South African Distinguished Scientist award for her outstanding contribution to improving the quality of life of women and, in 2006, was given a lifetime achievement award by Amanitare, a pan African NGO dedicated to the rights of African women and children.